According to a recent LinkedIn post from Tipalti, biotechnology company ImaginAb has overhauled its finance technology stack to address bottlenecks in its accounts payable workflows. The post describes how manual invoice routing and purchase order matching were consuming significant staff time and delaying financial close processes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that ImaginAb adopted Sage Intacct as a core system and integrated Tipalti to automate global invoice processing and multi‑currency payments. The post attributes to this setup the elimination of 1,750 hours of manual work annually, removal of audit deficiencies in accounts payable, and a materially faster month‑end close.
From an investor perspective, the post suggests Tipalti’s value proposition centers on efficiency gains, audit readiness, and freeing finance teams for strategic work such as fundraising and staff development. If such outcomes are broadly replicable, they could support Tipalti’s customer acquisition efforts, deepen integrations within existing clients, and potentially improve recurring revenue visibility in the mid‑market and growth‑stage enterprise segment.
Within the wider fintech and payments automation space, the example of ImaginAb underscores continued demand for automated AP and multi‑currency payment solutions in complex, regulated industries like biotech. This may signal ongoing momentum for platforms positioned as part of a cloud‑based finance stack, potentially enhancing Tipalti’s competitive standing versus legacy AP tools and manual processes.